Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors

PURPOSE: To assess the incidence of BCR‐ABL kinase domain (KD) mutation detection and its prognostic significance in chronic phase chronic myeloid leukemia (CP‐CML) patients treated with tyrosine kinase inhibitors (TKIs). PATIENTS AND METHODS: We analyzed characteristics and outcome of 253 CP‐CML pa...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Med
Prif Awduron: Etienne, Gabriel, Dulucq, Stéphanie, Huguet, Françoise, Schmitt, Anna, Lascaux, Axelle, Hayette, Sandrine, Fort, Marie‐Pierre, Sujobert, Pierre, Bijou, Fontanet, Morisset, Stéphane, Tavitian, Suzanne, Bidet, Audrey, Turcq, Beatrice, Robbesyn, Fanny, Chollet, Claudine, Belloc, Francis, Durrieu, Françoise, Mahon, François‐Xavier, Nicolini, Franck E.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2019
Pynciau:
Clinical Cancer Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6718576/
https://ncbi.nlm.nih.gov/pubmed/31350815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2410
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg